Related Experiment Videos

Double-blind study of cetirizine in atopic eczema in children

M La Rosa1, C Ranno, I Musarra

  • 1Department of Pediatrics, University of Cagliari, Italy.

Annals of Allergy
|August 1, 1994
PubMed

Insights

Cetirizine significantly reduced itching and skin symptoms in children with atopic eczema over 8 weeks. This allergy medication demonstrated effectiveness without causing noticeable side effects like drowsiness.

Area of Science:

  • Dermatology
  • Allergology
  • Pediatrics

Background:

  • Atopic eczema is a common chronic inflammatory skin condition in children.
  • Pruritus and cutaneous symptoms significantly impact children's quality of life.

Purpose of the Study:

  • To evaluate the clinical efficacy of cetirizine in managing atopic eczema in children.
  • To assess the impact of cetirizine on pruritus and other dermatological symptoms.

Main Methods:

  • An 8-week, double-blind, placebo-controlled study.
  • Inclusion criteria based on Hanifin and Rajka diagnostic criteria for atopic dermatitis.
  • Assessment of pruritus, erythema, and lichenification using diary card scores.

Main Results:

  • Cetirizine treatment led to a statistically significant and rapid decrease in pruritus compared to placebo.
  • Significant reduction in erythema and lichenification observed in the cetirizine group.
  • No observable side effects such as somnolence or decreased attention were reported by parents.

Conclusions:

  • Cetirizine demonstrates significant efficacy in controlling pruritus and cutaneous symptoms of atopic eczema in children.
  • The study suggests cetirizine is a safe and effective treatment option for pediatric atopic eczema.
  • Further research is warranted to confirm these preliminary findings.

Related Concept Videos